Biological Defense Systems

Keith@KeithsNetwork.com +1.7754507793

Biological Defense Systems

Keith@KeithsNetwork.com +1.7754507793

Conductive Polymer Biosensor Solutions for Biodefense

Conductive Polymer Biosensor Solutions for BiodefenseConductive Polymer Biosensor Solutions for BiodefenseConductive Polymer Biosensor Solutions for Biodefense

Enhancing safety through a patented "EYE-D" visual detection product that requires no sampling or secondary reagent.

Conductive Polymer Biosensor Solutions for Biodefense

Conductive Polymer Biosensor Solutions for BiodefenseConductive Polymer Biosensor Solutions for BiodefenseConductive Polymer Biosensor Solutions for Biodefense

Enhancing safety through a patented "EYE-D" visual detection product that requires no sampling or secondary reagent.

The Bio-ID sensor

Welcome to Biological Defense Systems

The intellectual property was filed using three of the top patent firms in the United States.  

This was to develop the broadest description of the technology in creating the most legally defensible patent product.

These patents are independently owned and funded.

 

Revolutionizing Medicine

Innovative Biotechnology Solutions at Biological Defense Systems

 In today’s rapidly evolving technological landscape, innovations that enhance safety and efficiency are highly sought after. One such breakthrough is a technology that visually monitors products for pathogens or toxins, providing alerts when these harmful agents are detected without the need for traditional testing. 

These integrated sensors are always "On", signaling the moment the contamination occurs.  

  

The success of any technology hinges on its ability to meet the needs of its target market. For a product that visually monitors for pathogens or toxins, the following markets are ideal:

· Food and Beverage Industry: Ensuring the safety of consumables is paramount. This technology can be indispensable for monitoring fresh produce, meat, dairy, and beverages.

· Pharmaceuticals: Maintaining sterile environments and ensuring the absence of contaminants in medications can significantly benefit from this technology.

· Healthcare: Hospitals and clinics can use this system to monitor medical equipment and supplies, reducing the risk of infections.

· Agriculture: Farmers and agricultural businesses can utilize this technology to ensure crops and livestock are free from harmful pathogens.



By integrating this technology into existing products, many of the cost may be eliminated or reduced and time to market and profitability is significantly accelerated.  The initial manufacturing of the economies of scale that would be required for quantities necessary have been addressed.  Thus, much of the design and product integration would be assumed by the owner of the product being enhanced.

  

· Enhanced Safety: Early detection of pathogens or toxins can prevent widespread contamination and potential health hazards.

· Compliance and Standards: Helps businesses comply with safety regulations and standards, avoiding legal issues and enhancing their reputation.

· Ease of Use: Designed to be user-friendly, requiring minimal training for staff to operate effectively.


  · Real-time Monitoring: Unlike traditional testing methods, this technology provides instant results, allowing for immediate action.

· Cost-Effective: Eliminating the need for regular testing saves considerable time and money.

· Enhanced Safety: Early detection of pathogens or toxins can prevent widespread contamination and potential health hazards.

· Compliance and Standards: Helps businesses comply with safety regulations and standards, avoiding legal issues and enhancing their reputation.

· Ease of Use: Designed to be user-friendly, requiring minimal training for staff to operate effectively.


Early detection allows for the containment of a threat before it spreads.


About Biological Defense Systems

Innovative Research

This video  is an example of just one application of this technology.

 

 The surgical mask is an example of a Bio-ID Sensor activated by a virus such as Influenza H1N1, Bird Flu (H5N1), Ebola or a TB bacterium. The mask can show activation on the outside thereby representing exposure to such virus or independently on the inside thereby representing early detection to the user that they have the infection and need to seek medical attention to prevent further spread and to effectively utilize medical intervention. An example of a practical application, the surgical mask can be used to screen patients entering the hospital admissions process.  


This intellectual property isn't a single product or application but rather a technology that can be employed throughout any industry where contaminants are a concern.  


I am seeking a strategic partner to collaborate and participate in the release of my fully developed product.   This partner will Play an integral role in the products launch, marketing and distribution. 


BDS’s mission is to put effective, inexpensive systems in place that provide for early, visual warning systems that detect for chemical and biological weapons, viruses, bacteria, toxins and volatile organic compounds (VOC’s).


These Bio-ID Sensors can be integrated into any fibrous or pulp product such as cardboard, paper, and various product packaging materials. Existing products may be enhanced with sensing capabilities creating a "value add" for immediate market penetration. (BDS’ patents claims also include woven /non-woven fabrics, composites, electro-spun fibers as well as solgel, hydrogel and aerogel. The sensor can target any molecule that a ligand can be created for, be it chemical, viral or biological. When a specific target has been detected, such as influenza, the product in which the Bio-ID Sensor has been integrated will   turn a specific color which will signify the presence of the specific target.


The diagram on the patents show how easily it can be integrated into an existing paper manufacturing process as an example.


Video

Mail / Postage

EARLY DETECTION SAVES LIVES

One of the primary inspirations for developing the conductive polymer biosensor was the anthrax attacks distributed in the mail post 9/11/2001.


When the anthrax was released in the postal system, the initial symptoms of exposure didn't  develop until 24 to 48 hours after exposure.  


Patients who receive early diagnosis and treatment within the 12-hour window have 

have reported survival rates of up to 80%, but, If treatment is delayed beyond this critical window, the mortality rate can exceed 90%.   


Additionally,  cross contamination between packages and envelopes can identify and leave a trail to the source of the threat. 

Food Packaging

The food packaging market in the United States is a robust and evolving industry, driven by consumer demands for convenience, sustainability, and innovation. With a market size estimated at $70 billion and a promising growth trajectory, the sector offers numerous opportunities for companies to thrive by addressing challenges and embracing new trends. As technological advancements continue and environmental consciousness grows, the future of food packaging will likely see even more transformative changes, making it an exciting field to watch.

Masks / PPE

 The surgical mask is an example of a Bio-ID Sensor activated by a virus such as Influenza H1N1, Ebola or a TB bacterium. The mask can show activation on the outside thereby representing exposure to such virus or independently on the inside thereby representing early detection to the user that they have the infection and need to seek medical attention to prevent further spread and to effectively utilize medical intervention. An example of a practical application, the surgical mask can be used to screen patients entering the hospital admissions process.  

Patents awarded

United States Patent 7527981 (pdf)

Download

United States Patent 8361810 (pdf)

Download

United States Patent 9023660 (pdf)

Download

Proof of selectivity / sensitivity / colorimetric response

The following papers represent a fraction of the  independent research of the technology that is covered by the aforementioned patents

Aptamer and DNAzyme Based Colorimetric Biosensors for Pathogen Detection 2024 (pdf)Download
Naked-eye detection of pandemic influenza a (pH1N1) (PDA)-based paper sensor 2024 (pdf)Download
Colorimetric Polydiacetylene−Aerogel Detector for Volatile OrganicCompounds (VOCs) 2020 (pdf)Download
Next‐Generation Wound Care Aptamer‐Conjugated Polydiacetylene Polyurethane 2024 (pdf)Download
Smartphone-based polydiacetylene colorimetric sensor for point-of-care 2024 (pdf)Download
Rapid detection of Salmonella with naked-eye colorimetric sensing (pdf)Download
Polydiacetylene (PDA) Embedded Polymer-Based Network Structure for Biosensor Applications (pdf)Download

PHD & Masters Thesis on PDA - the future

Most United States Universities now have departments devoted to polydiacetylene and other conductive polymer research for pathogen detection.  There is also a significant  amount of research  being done in China, South Korea, Israel and other countries. These are just a few of the more recent publications, however, there are many more than can be listed here. The strength of the patented intellectual property that I own allows me to benefit from continued research.

Phd Thesis - Phd Beglaryan_Stella_tesi (pdf)Download
Phd Thesis - Polydiacetylenes for Colorimetric Sensing -2024 (pdf)Download
White Paper - Conjugated Polymers for Aptasensing Applications - 2023 (pdf)Download

conductive polymer visual biosensor

Why We Need A One Step Label Free Biosensor

  

Until we can objectively define illness and toxins in our population and environment, we are subject to the policies of this rogue medical establishment,

The fact that there are pathogens and toxins that we cannot see, this allows the globalists to lock-down, quarantine and mandate vaccines through fear and intimidation.

Additionally, since we cannot see the toxins, venom's, chemicals, and other pathogens in our food water and air, we are defenseless against the threats and attacks that cause disease and sickness.

The PCR test that is the current standard for pathogen detection (which, takes between 48 and 96 hours to obtain a result) is a fraud that is easily manipulated by the number of cycles run) and is being used to validate the agenda of the globalists to mandate their controls, close our churches and business, recall our food, cull our chicken beef and pork.  Prohibit our eggs, milk and dairy and mandate their vaccines.

What Is The Solution

  

The product can be easily integrated into most manufacturing processes such as but not limited to: pulp and paper, most compounds and/or fibrous networks as well as woven and unwoven cloth,  electro-spun fibers, solgel, hydrogel and aerogel.  The uniqueness of the technology allows the product to have significant performance improvements via a 3-D architecture for increased surface area, two-sided detection and a simplified and robust approach for integrating into existing manufacturing processes. In most integrated applications the technology actually uses the product substrate to wick or diffuse the threat analyte into or around the architecture and corresponding biosensors thereby creating an extremely efficient and precise recognition system especially in cases of smallest quantities and earliest detection of an analyte.


Furthermore, the Bio-ID Sensor color change can be made to occur outside the spectrum of the human eye so, if the purchaser so wishes, the color is only visible under a blacklight or other detection device. This might be a beneficial  feature if authorities are covertly using the sensor to detect drugs or explosives.


These Bio-ID Sensors are non toxic and environmentally friendly. Many of the ingredients, such as Polydiacetylenes, are currently being used in the food industry. Components such as the silica sol-gel can be processed using complete organic materials. Hydrogels are currently being used in the healthcare industries in products such as wound dressings and the gels actually surround and penetrate the wound.  


How This Is Different

Many of the obstacles that limit the effectiveness of colorimetric response, selectivity, sensitivity and shelf-live may be overcome through the substrate in which the technology is presented. Integrating polydiacetylene into a substrate offers numerous advantages over a surface application. These include significantly increased surface area, light wave amplification, creating a hydrophobic or hydrophilic sensor environment as well as protecting the polydiacetylene from environmental factors such as heat or friction. 


This also allows for the integration of the sensor into the manufacturing process for a “value add” to an existing product such as a mask, wound wrap or food packaging.  This would  minimize the marketing required to launch a large scale product release.

Value Proposition

  

· High sensitivity and specificity: PDA biosensors can detect low concentrations of target molecules, making them ideal for early diagnosis of diseases.


· Cost-effectiveness: The materials and production processes involved in creating PDA biosensors are relatively inexpensive compared to traditional diagnostic methods.


· Ease of use: These biosensors often provide quick and straightforward readouts, which can be easily interpreted without the need for complex equipment or extensive training.


· Portability: PDA biosensors are typically small and lightweight, enabling their use in a variety of settings, including remote or resource-limited environments.


· Scalability: The technology can  easily be integrated into numerous compounds, from packaging to fabrics and plastics.

  

· The medical prognosis of recovery following exposure to a toxin or pathogen is greatly enhanced when assessment and intervention occur within the first 24 hours. Early detection allows for timely and targeted treatments, reducing the severity of symptoms, preventing complications, and improving overall patient outcomes. Despite the challenges, prioritizing early assessment in medical practice is essential for optimizing recovery and saving lives.


Value Add - Integrate into existing products

 BDS’ Eye-D technology provides a "Value Add" to many existing and popular products.


Whereas most testing requires sampling and processing, these  sensors are always "On", signaling the moment the contamination occurs.  Early detection allows for the containment of a threat before it spreads.


Unlike the release of a new product line which requires manufacturing,  advertising, packaging,  sales et. By integrating this technology into existing products, many of these cost may be eliminated or reduced and time to market and profitability is significantly accelerated.  The initial manufacturing of the economies of scale that would be required for quantities necessary have been addressed.  Thus, much of the design and product integration would be assumed by the owner of the product being enhanced.


Innovative Biotech Solutions

Food Packaging

Wound Wrap / Bandage

Food Packaging

  

The food packaging market in the United States is a robust and evolving industry, driven by consumer demands for convenience, sustainability, and innovation. With a market size estimated at $70 billion and a promising growth trajectory, the sector offers numerous opportunities for companies to thrive by addressing challenges and embracing new trends. As technological advancements continue and environmental consciousness grows, the future of food packaging will likely see even more transformative changes, making it an exciting field to watch.

Mail / Postage

Wound Wrap / Bandage

Food Packaging

  

EARLY DETECTION SAVES LIVES

One of the primary inspirations for developing the conductive polymer biosensor was the anthrax attacks distributed in the mail post 9/11/2001.


When the anthrax was released in the postal system, the initial symptoms of exposure didn't  develop until 24 to 48 hours after exposure.  


Patients who receive early diagnosis and treatment within the 12-hour window have 

have reported survival rates of up to 80%, but, If treatment is delayed beyond this critical window, the mortality rate can exceed 90%.   


Additionally,  cross contamination between packages and envelopes can identify and leave a trail to the source of the threat. 

Wound Wrap / Bandage

Wound Wrap / Bandage

Wound Wrap / Bandage

  

As of 2023, the wound care market in the United States was valued at approximately $10.12 billion, with wound wraps comprising a substantial portion of this figure. The market is projected to grow at a compound annual growth rate (CAGR) of around 5.3% from 2022 to 2027. This growth is attributed to the rising incidence of chronic wounds, surgical procedures, and traumatic injuries, which necessitate effective wound management solutions.


Food Packaging

PDA Biosensors Potential

Wound Wrap / Bandage

  

The food packaging market in the United States is a robust and evolving industry, driven by consumer demands for convenience, sustainability, and innovation. With a market size estimated at $70 billion and a promising growth trajectory, the sector offers numerous opportunities for companies to thrive by addressing challenges and embracing new trends. As technological advancements continue and environmental consciousness grows, the future of food packaging will likely see even more transformative changes, making it an exciting field to watch.

Real-time Water Testing

PDA Biosensors Potential

PDA Biosensors Potential

  

As of recent estimates, the real-time water testing market in the United States is valued at approximately $1.2 billion. This valuation is projected to increase steadily, reflecting a compound annual growth rate (CAGR) of around 6-7% over the next five years.

The future of the real-time water testing market in the United States looks promising, driven by continued technological innovations and an ever-growing focus on environmental sustainability. Investment in R&D, combined with collaborative efforts between public and private sectors, is expected to further propel the market forward.

PDA Biosensors Potential

PDA Biosensors Potential

PDA Biosensors Potential

  

Pandemic detection from covid to bird flu in real time.


The revenue potential for PDA biosensors is significant. Market research indicates that the global biosensor market was valued at approximately $27 billion in 2021 and is projected to reach $49 billion by 2026, with a compound annual growth rate (CAGR) of 12.3%. Given the specific advantages of PDA biosensors, they are likely to capture a considerable share of this expanding market.



Biological Defense Systems

P.O. Box 1231 Panguitch UT 84759

Keith@KeithsNetwork.com +1.7754507793

Copyright © 2025 Biological Defense Systems - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept